Pre-market Gainers: BofI Holding, Inc. (NASDAQ:BOFI), Hansen Medical, Inc ... Gaining Green Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced that the European Commission (EC) has approved Roche's new subcutaneous (SC) formulation of MabThera® (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell ... |
